BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16978776)

  • 1. RhoA protein expression correlates positively with degree of malignancy in astrocytomas.
    Yan B; Chour HH; Peh BK; Lim C; Salto-Tellez M
    Neurosci Lett; 2006 Oct; 407(2):124-6. PubMed ID: 16978776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
    Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade astrocytomas show increased Nestin and Wilms's tumor gene (WT1) protein expression.
    Rushing EJ; Sandberg GD; Horkayne-Szakaly I
    Int J Surg Pathol; 2010 Aug; 18(4):255-9. PubMed ID: 19578047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of thyroid hormone receptor isoforms in human astrocytomas.
    Hwang SL; Lin CL; Lieu AS; Hwang YF; Howng SL; Hong YR; Chang DS; Lee KS
    Surg Neurol; 2008 Dec; 70 Suppl 1():S1:4-8; discussion S1:8. PubMed ID: 18617237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical study of proliferation index of astrocytomas classified by new histopathological grading].
    Takekawa Y; Sawada T; Sakurai I
    Rinsho Byori; 1995 May; 43(5):483-6. PubMed ID: 7783368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells.
    Quick Q; Skalli O
    Exp Cell Res; 2010 Apr; 316(7):1137-47. PubMed ID: 20156433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
    Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
    Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
    Erdamar S; Bagci P; Oz B; Dirican A
    J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TNKS1 is correlated with pathologic grade and Wnt/β-catenin pathway in human astrocytomas.
    Tang B; Wang J; Fang J; Jiang B; Zhang M; Wang Y; Yang Z
    J Clin Neurosci; 2012 Jan; 19(1):139-43. PubMed ID: 22154485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A2B5 lineages of human astrocytic tumors and their recurrence.
    Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
    Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas.
    Birlik B; Canda S; Ozer E
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):532-8. PubMed ID: 16972887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry.
    Cao L; Cao W; Zhang W; Lin H; Yang X; Zhen H; Cheng J; Dong W; Huo J; Zhang X
    Neurosci Lett; 2008 Feb; 432(2):94-9. PubMed ID: 18242847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-pathological analysis of pilocytic astrocytomas and gangliogliomas.
    Fiks T; Jesionek-Kupnicka D; Zakrzewski K; Polis L; Liberski PP
    Pol J Pathol; 2001; 52(1-2):47-51. PubMed ID: 11505680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.